Literature DB >> 19809865

Cell-derived soluble oligomers of human amyloid-beta peptides disturb cellular homeostasis and induce apoptosis in primary hippocampal neurons.

Ting-Ting Yang1, Chao-Tien Hsu, Yu-Min Kuo.   

Abstract

The concentrations of soluble beta-amyloid (Abeta) oligomers paralleled with the extent of synaptic loss and severity of cognitive impairment in Alzheimer patients. However, the neurotoxicity of the naturally generated Abeta species remains unknown. This study was designed to examine the effects of naturally generated Abeta oligomers, secreted from amyloid precursor protein-expressing cells, on the homeostasis and viability of primary hippocampal neurons. Our results showed that primary hippocampal neurons incubated with condition media containing cell-secreted soluble Abeta had higher levels of heat-shock protein (HSP)27, HSP60 and HSP70, and lower levels of HSP32 than those of the control neurons. The cell-secreted soluble Abeta caused mitochondria dysfunction in hippocampal neurons as demonstrated by depolarized membrane potential and decreased cytochrome c oxidase activity and ATP levels. The levels of pro-apoptotic proteins, Bid, Bax and cytochrome C, were elevated; whereas anti-apoptotic Bcl-2 protein was reduced in the soluble Abeta-cultured neurons. Apoptosis was also evident in these soluble Abeta-cultured neurons. These results indicate that naturally secreted Abeta induces neuronal injury/death by activating an apoptotic pathway involving impaired mitochondria function and cellular homeostasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19809865     DOI: 10.1007/s00702-009-0311-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  47 in total

1.  Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

Authors:  C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

2.  Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.

Authors:  P D Mehta; T Pirttilä; S P Mehta; E A Sersen; P S Aisen; H M Wisniewski
Journal:  Arch Neurol       Date:  2000-01

Review 3.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

4.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

5.  Mitochondrial membrane potential monitored by JC-1 dye.

Authors:  M Reers; S T Smiley; C Mottola-Hartshorn; A Chen; M Lin; L B Chen
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

6.  Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

Authors:  L F Lue; Y M Kuo; A E Roher; L Brachova; Y Shen; L Sue; T Beach; J H Kurth; R E Rydel; J Rogers
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

7.  Abeta(31-35) and Abeta(25-35) fragments of amyloid beta-protein induce cellular death through apoptotic signals: Role of the redox state of methionine-35.

Authors:  M Elisabetta Clementi; Stefano Marini; Massimo Coletta; Federica Orsini; Bruno Giardina; Francesco Misiti
Journal:  FEBS Lett       Date:  2005-05-23       Impact factor: 4.124

8.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

Authors:  M Shoji; T E Golde; J Ghiso; T T Cheung; S Estus; L M Shaffer; X D Cai; D M McKay; R Tintner; B Frangione
Journal:  Science       Date:  1992-10-02       Impact factor: 47.728

9.  Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.

Authors:  R Katzman; R Terry; R DeTeresa; T Brown; P Davies; P Fuld; X Renbing; A Peck
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

10.  Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease.

Authors:  Y M Kuo; S Webster; M R Emmerling; A E Roher
Journal:  Biochim Biophys Acta       Date:  1998-04-28
View more
  13 in total

1.  Hypoxia Inducible Factors Modulate Mitochondrial Oxygen Consumption and Transcriptional Regulation of Nuclear-Encoded Electron Transport Chain Genes.

Authors:  Hye Jin Hwang; Scott G Lynn; Ajith Vengellur; Yogesh Saini; Elizabeth A Grier; Shelagh M Ferguson-Miller; John J LaPres
Journal:  Biochemistry       Date:  2015-06-12       Impact factor: 3.162

2.  Mitochondrial-targeted aryl hydrocarbon receptor and the impact of 2,3,7,8-tetrachlorodibenzo-p-dioxin on cellular respiration and the mitochondrial proteome.

Authors:  Hye Jin Hwang; Peter Dornbos; Michelle Steidemann; Taylor K Dunivin; Mike Rizzo; John J LaPres
Journal:  Toxicol Appl Pharmacol       Date:  2016-04-20       Impact factor: 4.219

Review 3.  S-glutathionylation: from molecular mechanisms to health outcomes.

Authors:  Ying Xiong; Joachim D Uys; Kenneth D Tew; Danyelle M Townsend
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

4.  Changes in insulin-signaling transduction pathway underlie learning/memory deficits in an Alzheimer's disease rat model.

Authors:  Xiaojuan Han; Yan Ma; Xiaohui Liu; Lu Wang; Shen Qi; Qinghua Zhang; Yifeng Du
Journal:  J Neural Transm (Vienna)       Date:  2012-04-17       Impact factor: 3.575

Review 5.  Unraveling the early events of amyloid-β protein (Aβ) aggregation: techniques for the determination of Aβ aggregate size.

Authors:  N Elizabeth Pryor; Melissa A Moss; Christa N Hestekin
Journal:  Int J Mol Sci       Date:  2012-03-07       Impact factor: 6.208

6.  Hsp60 response in experimental and human temporal lobe epilepsy.

Authors:  Antonella Marino Gammazza; Roberto Colangeli; Gergely Orban; Massimo Pierucci; Giancarlo Di Gennaro; Margherita Lo Bello; Alfredo D'Aniello; Fabio Bucchieri; Cristoforo Pomara; Mario Valentino; Richard Muscat; Arcangelo Benigno; Giovanni Zummo; Everly Conway de Macario; Francesco Cappello; Giuseppe Di Giovanni; Alberto J L Macario
Journal:  Sci Rep       Date:  2015-03-24       Impact factor: 4.379

Review 7.  Amyloid-beta immunotherapy: the hope for Alzheimer disease?

Authors:  Alvaro Barrera-Ocampo; Francisco Lopera
Journal:  Colomb Med (Cali)       Date:  2016-12-30

8.  Mechanistic perspectives on differential mitochondrial-based neuroprotective effects of several carnitine forms in Alzheimer's disease in vitro model.

Authors:  Sandra I Mota; Inês Pita; Rodolfo Águas; Slah Tagorti; Ashraf Virmani; Frederico C Pereira; A Cristina Rego
Journal:  Arch Toxicol       Date:  2021-06-24       Impact factor: 5.153

9.  Amyloid-β oligomers regulate the properties of human neural stem cells through GSK-3β signaling.

Authors:  Il-Shin Lee; Kwangsoo Jung; Il-Sun Kim; Kook In Park
Journal:  Exp Mol Med       Date:  2013-11-15       Impact factor: 8.718

10.  Data on AHR-dependent changes in the mitochondrial proteome in response to ,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Hye Jin Hwang; Peter Dornbos; John J LaPres
Journal:  Data Brief       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.